SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-13-005432
Filing Date
2013-05-07
Accepted
2013-05-07 16:49:50
Documents
3
Period of Report
2013-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K furx20130506_8k.htm 8-K 19289
2 EXHIBIT 99.1 furx20130506_8kex99-1.htm EX-99 124045
3 furx20130506_8kex99-1img001.jpg GRAPHIC 6889
  Complete submission text file 0001437749-13-005432.txt   154234
Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Filer) CIK: 0001484478 (see all company filings)

IRS No.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34641 | Film No.: 13820949
SIC: 2834 Pharmaceutical Preparations